BTG3 and overlapping connective tissue disease: In AMA‐negative patients, the diagnosis is based on serology (ANA/ASMA titers) and histopathology, as demonstrated in our case, where strong ANA positivity and classic portal interface activity confirmed the diagnosis of overlap syndrome [13].